October 16, 2017
by Dentsply Sirona
Dentsply Sirona, The Dental Solutions Company™, today announced the appointment of two new Executive Leadership Team members, effective immediately, as part of their continuing efforts to position the Company to achieve its potential.
Nick Alexos joins as EVP, Chief Administrative Officer, reporting directly to Mark Thierer, Interim Chief Executive Officer. In this role, he will lead Treasury, Information Technology, Business Development, Strategic Planning, and Investor Relations.
Mr. Alexos was most recently with Madison Dearborn Partners LLC, a leading Chicago-based private equity firm which he co-founded. Prior to that, he was with First Chicago Venture Capital and the First National Bank of Chicago. He is a CPA and received his MBA from The University of Chicago Booth School of Business.
“I have worked with Nick for nearly two decades. He has extensive experience in the healthcare sector as an investor and as a member of a number of boards in the industry, including Sirona Dental Systems, Inc.,” said Mark Thierer, Interim Chief Executive Officer of Dentsply Sirona. “Nick will be an outstanding leader and business partner focusing on capital deployment, operating leverage expansion, and potential acquisitions.”
In addition, the Company announced that Keith Ebling joins as EVP, General Counsel & Secretary, also reporting to Mark Thierer. He replaces Jonathan Friedman who resigned from the Company.
Mr. Ebling comes to Dentsply Sirona from Express Scripts Holding Company, a $100 billion integrated pharmacy benefit management company. He served in a number of legal and leadership roles over his nearly 20 years with the company, most recently as Executive Vice President and General Counsel. Prior to that, Mr. Ebling was an associate with a private firm in St. Louis that he joined after graduating as valedictorian and magna cum laude from Saint Louis University School of Law. He also has his MBA from Washington University Olin School of Business.
Said Thierer: “I have known Keith for years. He has deep General Counsel expertise and brings significant experience in the areas of product development, business development, and mergers and acquisitions. We are fortunate to have someone with Keith’s expertise to guide us from a legal perspective as we position Dentsply Sirona for growth.”
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company™, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. Dentsply Sirona’s global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
read more >>